SecBot SecBot
GOVT-CONTRACT ·Filed Aug 31, 2026

LDOS

Leidos Holdings, Inc.
BULLISH
Impact 5/10
Horizonmonths Processed2mo ago
Large government contract award ($500M+)
Actionable Insight ▲ Bullish

The $113.7M modification adds to Leidos's backlog and confirms a strong relationship with HHS/NCI. Traders should monitor for additional task orders under this IDIQ vehicle and any future earnings calls that may provide updated revenue guidance reflecting this award.

DirectionBullish
Confidencehigh
Horizonmonths

How the stock moved after the report

⚠ Clustered BULLISH VIEWSTOCK BELOW ENTRY AT T+20
Entry
$138.73
T+0 close · Sep 1, 2026 · via day close
Latest settled
−12.18%
T+20 · $121.83 · next T+60 in 8d
Vs SPY
−12.54%
α at T+20
Latest observation
−6.00%
T+52 · FF3 residual α
  1. T+0 · Sep 1 $138.73entry
  2. T+1 · 3mo ago −3.88%α −4.32% · $133.35
  3. T+5 · 2mo ago −7.93%α −8.01% · $127.73
  4. T+20 · 7w ago −12.18%α −12.54% · $121.83
  5. T+53 · todayOpen
  6. T+60 · in 8d Pending
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Leidos Biomedical Research Inc., a subsidiary of Leidos Holdings (LDOS), received a $113.7M modification to its NCI operational task order from the Department of Health and Human Services. This is a material contract action for a key federal customer, reinforcing Leidos's position in health IT and biomedical research services.

Key Financial Metrics

Action
Modification
Obligated
$113.7M
Agency
Department of Health and Human Services

Contract history

Every action SecBot has tracked on this contract, newest first; latest action 2026-09-30. Each amount is that action's figure: obligated by the action, the announced value, or for an award total, the award's value to date.

  • 2026-09-30 Modification $342.2Mobligated Mod P00014 · USAspending
  • 2026-08-31 Modification(this report) $113.7Mobligated Mod P00011 · USAspending
  • 2026-08-18 Modification $29.5Mobligated Mod P00010 · USAspending

Key Facts

  • Leidos Biomedical Research Inc. received a $113.7M modification (P00011) to contract 75N91025F00016 from the Department of Health and Human Services.
  • The modification is for the NCI Operational Task Order, covering FY26-FY27.
  • Action date is 2026-08-31.
  • The award is a modification to an existing contract, indicating ongoing work and a strong agency relationship.
  • Leidos's annual revenue is not available in the provided data, so revenue impact percentage cannot be calculated.

Financial Impact

$113.7M contract modification from HHS for NCI operational task order.

revenuebacklog

Risk Factors

  • Government funding risk from continuing resolutions or budget sequestration.
  • Execution risk on the operational task order.
  • Political/regulatory risk from changes in HHS or NCI priorities.

Market Snapshot

Exchange
NYSE
Sector
Services-Computer Integrated Systems Design
Analyst Consensus
48% bullish (25 analysts)

Investment Themes

Documents Analyzed

This report is based on 1 federal contract record from official U.S. government contract data.

DocumentAccession Number
GOVT-CONTRACT Data (Synthetic)contract-75N91025F00016

Track record

38 reports on LDOS

Performance horizon

5 of 6 bullish or bearish reports moved the stock their way by T+20. Best: +14.62% at T+20 after the Sep 29, 2026 report. 6 of 7 went positive at some point.

Filters
  1. Nov 2, 202614d ago 8-K Bullish 6/10 Entry $134.72 Now $130.02 −3.49% settles Dec 2
  2. Oct 30, 202617d ago Press Release Neutral 2/10 Entry $144.16 Now $130.02 −9.81% settles Dec 1
  3. Oct 23, 202624d ago Institutional Cluster Mixed 3/10 Entry $136.08 Now $130.02 −4.45% settles Nov 20
  4. Oct 14, 20264w ago Press Release Neutral 3/10 Entry $120.59 to $133.89 Now $130.02 +7.82% ▲ +11.03% +12.30% vs SPY
  5. Oct 13, 20265w ago GOVT-CONTRACT Neutral 3/10 Entry $120.59 to $133.89 Now $130.02 +7.82% ▲ +11.03% +12.30% vs SPY
  6. Oct 6, 20265w ago Press Release Neutral 1/10 Entry $116.69 Now $130.02 +11.42% No price data
  7. Oct 5, 20266w ago 8-K Neutral 5/10 Entry $119.45 to $142.98 Now $130.02 +8.85% ▲ +19.70% +22.16% vs SPY
  8. Oct 1, 20266w ago 8-K Neutral 2/10 Entry $121.97 to $141.02 Now $130.02 +6.60% ▲ +15.62% +14.92% vs SPY
  9. Oct 1, 20266w ago GOVT-CONTRACT Neutral 2/10 Entry $117.74 to $142.98 Now $130.02 +10.43% ▲ +21.44% +23.25% vs SPY
  10. Oct 1, 20266w ago GOVT-CONTRACT Neutral 3/10 Entry $117.74 to $142.98 Now $130.02 +10.43% ▲ +21.44% +23.25% vs SPY
Showing 10 of 38

US Market Status

Market Closed · Opens in 9h 11m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Sep 2, 2026